Case 3: Hepatosplenomegaly in a 2-year-old boy
10.1542/pir.36-6-265
Saved in:
Main Author: | Ramachandran, R |
---|---|
Other Authors: | PAEDIATRICS |
Format: | Article |
Published: |
American Academy of Pediatrics (AAP)
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/205842 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Real world experience of R-CHOP with or without consolidative radiotherapy vs DA-EPOCH-R in the first-line treatment of primary mediastinal B-cell lymphoma
by: Li Chan, Esther Hian, et al.
Published: (2021) -
Primary cardiac diffuse large B-cell lymphoma in immunocompetent patients: clinical, histologic, immunophenotypic, and genotypic features of 3 cases
by: Soon, Gwyneth, et al.
Published: (2021) -
Obinutuzumab (GA101) vs. rituximab significantly enhances cell death, antibody-dependent cytotoxicity and improves overall survival against CD20+ primary mediastinal B-cell lymphoma (PMBL) in a xenograft NOD-scid IL2Rgnull (NSG) mouse model: A potential targeted agent in the treatment of PMBL
by: Chu, Y., et al.
Published: (2021) -
A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma
by: Chng, WJ, et al.
Published: (2023) -
Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: Analysis from the Asia Lymphoma Study Group
by: Kim, S.J., et al.
Published: (2016)